TARDBP and amyotrophic lateral sclerosis: TDP-43 is heavily implicated in amyotrophic lateral sclerosis (ALS), frontotemporal dementia (FTD), and Alzheimer’s disease (AD), relentlessly progressive neurodegenerative diseases with no cure17.